Cadila Healthcare gets EIR from US FDA for its Ahmedabad facility
The facility completed the US FDA audit from December 16 to 20, 2019 with zero 483 observations, it added
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Novartis lung cancer drug gets priority US review
Capmatinib will be the first therapy to specifically target METex14 mutated advanced lung cancer
Govt taking steps to reduce country’s dependence on imports of antibiotic raw materials
"The policies formulated by Government from time to time are designed to minimize country's dependence on imports and to give…
Cipla SA signs agreement for anti-psychotic drug
The agreement involves AstraZeneca Pharmaceuticals, the originator of the Medicine, and Luye Pharma Hong Kong, which acquired the…
Executives call for track-and-trace schemes in Southeast Asia: CPhI Southeast Asia Report
Generics exports and harmonisation continuing apace, with Thailand forecast strong near-term opportunities
CPhI’s ASEAN Pharma…
JB Chemicals Gujarat unit passes US FDA inspection with one observation
The company proposes to address this observation in the next 15 days
JB Chemicals and Pharmaceuticals said its Gujarat unit has…
Cipla acquires four nutraceutical brands of Wanbury
The nutraceutical products will address various health needs for conditions arising due to nutritional deficiencies or…
Alkem Labs Q3 net profit up 90 per cent to Rs 390 cr
Consolidated revenue from operations stood at Rs 2,181.84 crore
Alkem Laboratories reported an 89.80 per cent rise in…
Lupin Q3 net loss widens to Rs 835 cr
Consolidated sales of the company stood at Rs 3,716 crore
Lupin reported widening of its consolidated net loss to Rs 835 crore…
ICT Mumbai to organise 2nd Edition of the Leadership Conclave 2020 in Mumbai
Panel sessions will focus on viewpoints, such as global health policies and their engagements with the Indian biopharma…